Saturday Edition
Stay updated with Archyde – your source for breaking news, global headlines, economy, entertainment, health, technology, and sports. Fresh stories daily.
The U.S. Food and Drug Administration (FDA) has declined to approve Galderma’s biologics license application for relabotulinumtoxinA. The regulatory agency cited specific concerns regarding manufacturing site inspections and analytical method ... Read More
Continuous Coverage
A male victim died following a drive-by shooting on the 6600 block of South Vermont Avenue in South…
MTV Lebanon reported on July 5, 2026, that the United States flag was raised at Beirut Airport. The…
Avian influenza A(H5N1) has been detected in poultry across Nepal, with genetic sequencing confirming a high identity to…
Author Tomi Adeyemi has stated she will not watch the first film adaptation of her 2018 novel, Children…
Orlando Gill’s critique of Paraguay’s footballing style, aired amid recent fixture challenges, has ignited debate over tactical adaptability…
Brown bears (*Ursus arctos*) navigated the extreme climatic fluctuations of the Pleistocene epoch by undergoing rapid, iterative morphological…
Global Affairs
Authorities in New South Wales confirmed the death of a 4-year-old boy, with initial reports suggesting he was…
Markets And Money
Green Packaging Expansion: Zöldövezet Shifts Market Dynamics with Strategic Investment Budapest-based sustainable packaging supplier Zöldövezet has secured a…
Digital Culture
The Honor Magic V6, launching globally this July 2026, introduces native integration for Apple AirPods, allowing Android users…
Science And Wellbeing
Researchers have validated a new polygenic risk score for gastric cancer using the UK Biobank, a large-scale biomedical…
Screen And Sound
South African hip-hop pioneer Riky Rick’s family has launched a Memorial Forest in the Free State, transforming grief…
Fixtures And Form
Marta Kostyuk advanced to the fourth round of Wimbledon after defeating Paula Navarro in a third-round match, according…
